Edgewell Personal Care CO 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
Edgewell Personal Care's Q3 fiscal 2026 results show modest net sales growth and stable adjusted EPS, alongside the completion of its Feminine Care segment divestiture.
NYSE
Edgewell Personal Care reports a net loss for the quarter driven by restructuring charges and a decline in adjusted earnings, despite a slight increase in net sales.
NYSE
Edgewell Personal Care Company reported a significant net loss in Q1 fiscal 2026, primarily driven by a goodwill impairment charge related to its Feminine Care divestiture and increased restructuring costs.
NYSE
Edgewell Personal Care Company reported a significant decline in third-quarter net earnings and sales, driven by volume decreases and increased promotional activity in North America.
NYSE
10-Q: Edgewell Personal Care Reports Q2 Fiscal 2025 Results: Sales Decline Amid Restructuring Efforts
Edgewell Personal Care's Q2 fiscal 2025 net sales decreased by 3.1% to $580.7 million, with restructuring and repositioning actions ongoing.
NYSE
10-Q: Edgewell Personal Care Reports Q1 Fiscal 2025 Results: Sales Decline Amid Restructuring Efforts
Edgewell Personal Care's Q1 2025 net sales decreased by 2.1% to $478.4 million, with a net loss of $2.1 million, as the company continues to execute its restructuring and repositioning plans.
NYSE
Edgewell Personal Care's third-quarter results show a slight decrease in net sales, with international growth partially offsetting declines in North America.
NYSE
Edgewell Personal Care saw a slight increase in net sales and improved profitability in the second quarter of 2024, with strong international performance offsetting declines in North America.
NYSE
Edgewell Personal Care saw a 4.2% increase in net sales in the first quarter of fiscal 2024, driven by international growth, but experienced a decrease in net earnings compared to the same period last year.